HC Wainwright reissued their buy rating on shares of Sutro Biopharma (NASDAQ:STRO – Free Report) in a research note published on Friday, Benzinga reports. They currently have a $16.00 target price on the stock. Separately, Wedbush decreased their price target on shares of Sutro Biopharma from $20.00 to $12.00 and set an outperform rating on […]
Theravance Biopharma (NASDAQ:TBPH) Rating Reiterated by HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Reiterates Buy Rating for Vor Biopharma (NYSE:VOR) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reiterated their buy rating on shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) in a report published on Friday, Benzinga reports. They currently have a $6.00 target price on the biopharmaceutical company’s stock. Separately, StockNews.com lowered shares of Arbutus Biopharma from a buy rating to a hold rating in a research note on […]
Ambrx Biopharma Inc. (NYSE:AMAM – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price […]